Benefit of complete revascularization in patients with multivessel coronary disease in the drug-eluting stent era

Circulation Journal

Volumn 76, Issue 7, 2012, Pages 1624-1630

  Chung, Jin Wook ^a,b   Park, Keun Ho ^c   Lee, Min Ho ^a   Park, Kyung Woo ^a   Park, Jin Shik ^d   Kang, Hyun Jae ^a   Koo, Bon Kwon ^a   Kwon, Yoo Wook ^a   Kim, Hyo Soo ^a  

^a Seoul National University Hospital   (South Korea)

^b Soonchunhyang University College of Medicine   (South Korea)

^c Chonnam National University Medical School   (South Korea)

^d Sejong Hospital   (South Korea)

Author keywords

Coronary artery disease; Drug eluting stents; Multivessel disease; Myocardial revascularization

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PACLITAXEL; RAPAMYCIN; ZOTAROLIMUS;

ADULT; AGE; AGED; ANGIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; GENDER; GLOMERULUS FILTRATION RATE; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; REPEAT PROCEDURE; REVASCULARIZATION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG-ELUTING STENTS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; REGISTRIES; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84863201962     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-1285     Document Type: Article

References (22)

1. Ong AT, Serruys PW. Complete revascularization: Coronary artery bypass graft surgery versus percutaneous coronary intervention. Circulation 2006; 114: 249-255.
2. Bart BA, Shaw LK, McCants CB Jr, Fortin DF, Lee KL, Califf RM, et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol 1997; 30: 1002-1008.
3. Hannan EL, Wu C, Walford G, Holmes DR, Jones RH, Sharma S, et al. Incomplete revascularization in the era of drug-eluting stents: Impact on adverse outcomes. JACC Cardiovasc Interv 2009; 2: 17-25.
4. Tamburino C, Angiolillo DJ, Capranzano P, Dimopoulos K, La Manna A, Barbagallo R, et al. Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents. Catheter Cardiovasc Interv 2008; 72: 448-456.
5. Song YB, Lee SY, Hahn JY, Choi SH, Choi JH, Lee SH, et al. Complete versus incomplete revascularization for treatment of multivessel coronary artery disease in the drug-eluting stent era. Heart Vessels 2011 July 16 [Epub ahead of print].
6. Vander Salm TJ, Kip KE, Jones RH, Schaff HV, Shemin RJ, Aldea GS, et al. What constitutes optimal surgical revascularization? Answers from the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol 2002; 39: 565-572.
7. van den Brand MJ, Rensing BJ, Morel MA, Foley DP, de Valk V, Breeman A, et al. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. J Am Coll Cardiol 2002; 39: 559-564.
8. Bell MR, Gersh BJ, Schaff HV, Holmes DR Jr, Fisher LD, Alderman EL, et al. Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery: A report from the Coronary Artery Surgery Study (CASS) Registry. Circulation 1992; 86: 446-457.
9. Buda AJ, Macdonald IL, Anderson MJ, Strauss HD, David TE, Berman ND. Long-term results following coronary bypass operation: Importance of preoperative actors and complete revascularization. J Thorac Cardiovasc Surg 1981; 82: 383-390.
10. Jones EL, Craver JM, Guyton RA, Bone DK, Hatcher CR Jr, Riechwald N. Importance of complete revascularization in performance of the coronary bypass operation. Am J Cardiol 1983; 51: 7-12.
11. Kleisli T, Cheng W, Jacobs MJ, Mirocha J, Derobertis MA, Kass RM, et al. In the current era, complete revascularization improves survival after coronary artery bypass surgery. J Thorac Cardiovasc Surg 2005; 129: 1283-1291.
12. Kozower BD, Moon MR, Barner HB, Moazami N, Lawton JS, Pasque MK, et al. Impact of complete revascularization on long-term survival after coronary artery bypass grafting in octogenarians. Ann Thorac Surg 2005; 80: 112-116; discussion 116-117.
13. Ijsselmuiden AJ, Ezechiels J, Westendorp IC, Tijssen JG, Kiemeneij F, Slagboom T, et al. Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: A randomized comparison. Am Heart J 2004; 148: 467-474.
14. Bourassa MG, Yeh W, Holubkov R, Sopko G, Detre KM. Long-term outcome of patients with incomplete vs complete revascularization after multivessel PTCA. A report from the NHLBI PTCA Registry. Eur Heart J 1998; 19: 103-111.
15. Hannan EL, Racz M, Holmes DR, King SB 3rd, Walford G, Ambrose JA, et al. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation 2006; 113: 2406-2412.
16. Kip KE, Bourassa MG, Jacobs AK, Schwartz L, Feit F, Alderman EL, et al. Influence of pre-PTCA strategy and initial PTCA result in patients with multivessel disease: The Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1999; 100: 910-917.
17. McLellan CS, Ghali WA, Labinaz M, Davis RB, Galbraith PD, Southern DA, et al. Association between completeness of percutaneous coronary revascularization and postprocedure outcomes. Am Heart J 2005; 150: 800-806.
18. Bell MR, Bailey KR, Reeder GS, Lapeyre AC 3rd, Holmes DR Jr. Percutaneous transluminal angioplasty in patients with multivessel coronary disease: How important is complete revascularization for cardiac event-free survival? J Am Coll Cardiol 1990; 16: 553-562.
19. Lehmann R, Fichtlscherer S, Schachinger V, Held L, Hobler C, Baier G, et al. Complete revascularization in patients undergoing multivessel PCI is an independent predictor of improved long-term survival. J Interv Cardiol 2010; 23: 256-263.
20. Takayama T, Hiro T, Hirayama A. Is angioplasty able to become the gold standard of treatment beyond bypass surgery for patients with multivessel coronary artery disease? Therapeutic strategies for 3-vessel coronary artery disease: OPCAB vs PCI (PCI-Side). Circ J 2010; 74: 2744-2749.
21. Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, Applegate R, et al. Safety and efficacy of drug-eluting and bare metal stents: Comprehensive meta-analysis of randomized trials and observational studies. Circulation 2009; 119: 3198-3206.
22. Mauri L, Silbaugh TS, Wolf RE, Zelevinsky K, Lovett A, Zhou Z, et al. Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts. Circulation 2008; 118: 1817-1827.